Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhuangya Biotechnology is a Chinese biotechnology company specializing in the development and manufacture of bioactive materials through synthetic biology. The company's core focus is on recombinant humanized collagen, specifically targeting applications in medical aesthetics, clinical dermatology, and wound healing. Zhuangya utilizes a proprietary synthetic biology platform to produce high-purity collagen types, such as Type I and Type III, which are used in medical dressings and injectable fillers. With several Class II and Class III medical device certifications, the company provides solutions for skin barrier repair and tissue regeneration. Zhuangya is positioned as a leader in the Chinese recombinant collagen market, competing in both the medical and high-end cosmetic sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuangya.